[Low-dose strong opioid (LDSO)--treatment of pain in osteoarthritis].
Bolten
W W
WW
Klaus-Miehlke-Klinik Leibnizstr. 23, D-65191 Wiesbaden. wbolten@em.uni-frankfurt.de
Böhme
K
K
Grifka
J
J
Schutter
U
U
Schwarz
H
H
Sittl
R
R
Sturm
D
D
Wahle
K
K
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy* / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D012307:Risk Factors; D013993:Tilidine / Q000008:administration & dosage / Q000627:therapeutic use; D014147:Tramadol / Q000008:administration & dosage / Q000627:therapeutic use
D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D009270:Naloxone; D014147:Tramadol; D002047:Buprenorphine; D013993:Tilidine